Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Avantis US Small Cap Value ETF (AVUV) vs Quest Diagnostics Inc (DGX) Price & Performance

Avantis US Small Cap Value ETFTrade
Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Avantis US Small Cap Value ETF vs Quest Diagnostics Inc — how do they compare? Avantis US Small Cap Value ETF trades at $127.5, while Quest Diagnostics Inc trades at $237.54 (market cap $26.21B). The key difference: Quest Diagnostics Inc pays a 1.45% dividend while Avantis US Small Cap Value ETF pays none. Which is the better fit depends on your goals.

AVUVDGX
Sector
Sector/ThematicHealth
52-Week High
$128.74$238.50
52-Week Low
$93.93$173.49
Market Cap
$26.21B
Enterprise Value
$31.97B
Dividend Yield
1.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Avantis US Small Cap Value ETF

AVUV trades at $127.50, up 0.39% with a bullish technical outlook supported by moving averages. The small-cap value ETF is benefiting from strong sector performance, with the Russell 2000 up approximately 20% year-to-date according to 24/7 Wall Street (July 17, 2026). Recent dividend activity includes a $0.44 distribution scheduled for June 2026.

The outlook remains positive as small-cap value continues outperforming growth stocks, with AVUV capturing this premium. Key risks include interest rate sensitivity and regional bank exposure, while institutional sentiment appears favorable given the ETF's role in diversifying tech-heavy portfolios.

Quest Diagnostics Inc

Quest Diagnostics (DGX) trades at $237.24, down 0.16% on the day, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $3.12 and raising its full-year outlook, driven by robust testing demand. Revenue grew to $11.04B in 2025, with net income of $992M, though margins face pressure from lower-margin deals and rising costs.

The outlook is positive due to raised guidance and AI integration enhancing efficiency, but risks include debt levels and margin compression. Analysts maintain a cautious buy stance with a $249.50 price target, indicating modest upside potential from current levels amid competitive and cost challenges.

Returns comparison

Trailing returns across standard periods

About Avantis US Small Cap Value ETF

AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.

Read more on AVUV

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX